Descripción
Cagrilintide + Semaglutide
| CAS Number | 129954-34-3 |
| Other Names | Selanc, TP-7, Thr-Lys-Pro-Arg-Pro-Gly-Pro, TP 7, UNII-TS9JR8EP1G, TS9JR8EP1G |
| IUPAC Name | (2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid |
| Molecular Formula | C33H57N11O9 |
| Molecular Weight | 751.9 |
| Purity | ≥99% Pure (LC-MS) |
| Liquid Availability | N/A |
| Powder Availability | N/A |
| Storage Condition | Store cold, keep refrigerated. Do NOT freeze. |
| Terms | All products are for laboratory developmental research USE ONLY. Products are not for human consumption. |
**Información Importante: Cada péptido se entrega liofilizado y debe ser reconstituido con Agua Bacteriostática para poder ser administrado en forma líquida.
Vea aquí el video sobre la reconstitución de péptidos
What is Cagrilintide + Semaglutide?
Cagrilintide + Semaglutide is a dual‑agonist combination blending an amylin analog (cagrilintide) with a GLP‑1 receptor agonist (Semaglutide). Clinical trials demonstrate superior weight reduction versus either agent alone, with the combination targeting complementary satiety pathways
How This Works
Cagrilintide is a long‑acting amylin analog that reduces appetite via central satiety pathways, while Semaglutide activates GLP‑1 receptors to enhance glucose‑dependent insulin secretion and suppress glucagon[4][5]. The combination leverages complementary mechanisms: amylin primarily delays gastric emptying and signals satiety through the area postrema, while GLP‑1 enhances pancreatic β‑cell function and central appetite suppression[1]. Clinical trials of the co‑administered regimen (CagriSema) show greater body‑weight reduction than either agent alone[2].
Disclaimer
**LAB USE ONLY**
*This information is for educational purposes only and does not constitute medical advice. THE PRODUCTS DESCRIBED HEREIN ARE FOR RESEARCH USE ONLY. All clinical research must be conducted with oversight from the appropriate Institutional Review Board (IRB). All preclinical research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC) following the guidelines of the Animal Welfare Act (AWA).
Citations
PEPTIDES PREFER THE COLD
Keep peptide vials refrigerated at all times to reduce peptide bond breakdown. DO NOT FREEZE. Most peptides, especially shorter ones, can be preserved for weeks if careful.
Always swab the top of the vial with an alcohol wipe or rubbing alcohol before accessing.
ONLY MIX WITH STERILE BACTERIOSTATIC WATER
The purity and sterility of bacteriostatic water are essential to prevent contamination and to preserve the shelf-life of dissolved peptides.
Push the pin through the rubber stopper at a slight angle, so that you inject the bacteriostatic water toward the inside wall of the vial, not directly onto the powder.
Lyophilized peptide should be stored at -20°C (freezer), and the reconstituted peptide solution at 4°C (refrigerated). Do not freeze once reconstituted.
NEVER SHAKE A VIAL TO MIX.
Air bubbles are unfavorable to the stability of proteins.
Cagrilintide + Semaglutide is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.
Valoraciones
No hay valoraciones aún.